600 related articles for article (PubMed ID: 26281203)
1. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
[TBL] [Abstract][Full Text] [Related]
2. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
[TBL] [Abstract][Full Text] [Related]
4. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
5. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease.
Lorenz EC; Sethi S; Poshusta TL; Ramirez-Alvarado M; Kumar S; Lager DJ; Fervenza FC; Leung N
Nephrol Dial Transplant; 2010 Apr; 25(4):1340-3. PubMed ID: 20061318
[TBL] [Abstract][Full Text] [Related]
6. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
[TBL] [Abstract][Full Text] [Related]
7. Kidney and liver involvement in monoclonal light chain disorders.
Pozzi C; Locatelli F
Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
[TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.
Zand L; Nasr SH; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Kumar S; Kyle RA; Fervenza FC; Sethi S; Dingli D; Rajkumar SV; Kapoor P; McCurdy A; Leung N
Leuk Lymphoma; 2015; 56(12):3357-64. PubMed ID: 25860232
[TBL] [Abstract][Full Text] [Related]
9. Nephrotoxic potential of Bence Jones proteins.
Solomon A; Weiss DT; Kattine AA
N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
[TBL] [Abstract][Full Text] [Related]
10. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
[TBL] [Abstract][Full Text] [Related]
11. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.
Gnemmi V; Leleu X; Provot F; Moulonguet F; Buob D
Am J Kidney Dis; 2012 Sep; 60(3):487-91. PubMed ID: 22721930
[TBL] [Abstract][Full Text] [Related]
12. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
Mohan M; Buros A; Mathur P; Gokden N; Singh M; Susanibar S; Jo Kamimoto J; Hoque S; Radhakrishnan M; Matin A; Davis C; Grazziutti M; Thanendrarajan S; van Rhee F; Zangari M; Davies F; Morgan G; Epstein J; Barlogie B; Schinke C
Am J Hematol; 2017 Aug; 92(8):739-745. PubMed ID: 28383130
[TBL] [Abstract][Full Text] [Related]
14. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells.
Keeling J; Teng J; Herrera GA
Lab Invest; 2004 Oct; 84(10):1322-38. PubMed ID: 15286662
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
16. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal proteins and renal disease.
Kyle RA
Annu Rev Med; 1994; 45():71-7. PubMed ID: 8198402
[TBL] [Abstract][Full Text] [Related]
18. Clinical challenges of an oligosecretory plasma cell dyscrasia.
Rodrigues L; Neves M; Sá H; Campos M
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23420725
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary light chain deposition disease: report of five cases and review of the literature.
Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
[TBL] [Abstract][Full Text] [Related]
20. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
